- Conditions: Urinary Incontinence; Multiple Sclerosis
Interventions: Biological: OnabotulinumtoxinA; Drug: Placebo (Normal Saline); OnabotulinumtoxinA
Sponsors: Allergan; Allergan
Not yet recruiting - verified May 2012 - Condition: Fecal Incontinence
Intervention: Biological: AMDC
Sponsors: Cook; Cook
Recruiting - verified May 2012 - Condition: Branch Retinal Vein Occlusion
Interventions: Drug: Ranibizumab; Procedure: Laser
Sponsors: Novartis; Novartis Pharmaceuticals
Not yet recruiting - verified May 2012 - Condition: ACL Injury
Intervention: Other: Core-PAC
Sponsors: University of British Columbia; University of British Columbia
Completed - verified May 2012 - Condition: Prediabetes
Intervention: Behavioral: Lifestyle changes
Sponsors: University of British Columbia; University of British Columbia; Canadian Institutes of Health Research (CIHR)
Not yet recruiting - verified April 2012 - Condition: Familial Chylomicronemia Syndrome (FCS) (HLP Type I)
Intervention: Drug: LCQ908
Sponsors: Novartis; Novartis Pharmaceuticals
Not yet recruiting - verified April 2012 - Condition: Respiratory Distress Syndrome
Interventions: Device: Neurally Adjusted Ventilatory Assist (NAVA); Device: SiPAP - placebo
Sponsors: Fraser Health; Fraser Health
Not yet recruiting - verified April 2012 - Condition: Vitamin B12 Deficiency
Interventions: Dietary Supplement: L-5-methyltetrahydrofolate (Metafolin ®); Dietary Supplement: folic acid; Dietary Supplement: Placebo
Sponsors: University of British Columbia; University of British Columbia
Not yet recruiting - verified April 2012 - Condition: Asthma
Interventions: Drug: MEMP1972A; Drug: MEMP1972A; Drug: MEMP1972A; Drug: placebo
Sponsors: Genentech; Genentech
Not yet recruiting - verified April 2012
 |
Paid Clinical Trials in British Columbia |
Clinical Trial Locations 